Mismatch between Bioluminescence Imaging (BLI) and MRI When Evaluating Glioblastoma Growth: Lessons from a Study Where BLI Suggested "Regression" while MRI Showed "Progression".

Bausart, Mathilde; Bozzato, Elia; Joudiou, Nicolas; Koutsoumpou, Xanthippi; Manshian, Bella; Préat, Véronique; Gallez, Bernard

Bausart, Mathilde; Bozzato, Elia; Joudiou, Nicolas; Koutsoumpou, Xanthippi; Manshian, Bella; Préat, Véronique; Gallez, Bernard.

Afiliação

Bausart M; Advanced Drug Delivery and Biomaterials (ADDB) Research Group, Louvain Drug Research Institute, Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
Bozzato E; Advanced Drug Delivery and Biomaterials (ADDB) Research Group, Louvain Drug Research Institute, Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
Joudiou N; Nuclear and Electron Spin Technologies (NEST) Platform, Louvain Drug Research Institute, Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
Koutsoumpou X; Department of Imaging and Pathology, Translational Cell and Tissue Research Unit, Katholiek Universiteit Leuven (KULeuven), 3000 Leuven, Belgium.
Manshian B; Department of Imaging and Pathology, Translational Cell and Tissue Research Unit, Katholiek Universiteit Leuven (KULeuven), 3000 Leuven, Belgium.
Préat V; Advanced Drug Delivery and Biomaterials (ADDB) Research Group, Louvain Drug Research Institute, Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
Gallez B; Biomedical Magnetic Resonance (REMA) Research Group, Louvain Drug Research Institute, Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.

Cancers (Basel) ; 15(6)2023 Mar 22.

Article em En | MEDLINE | ID: mdl-36980804